Authors
Michelle L Dew, Olubunkola M Olubi, Caroline Wang-Crocker, Emily L Prince, Annslee Lowe, D Elizabeth Le
Published in
Current cardiology reports. Volume 28. Issue 1. Aug 10, 2026. Epub Aug 10, 2026.
Abstract
To summarize the current understanding of the relationships between endogenous and exogenous androgens and cardiovascular disease in postmenopausal women.
Endogenous testosterone and dehydroepiandrosterone exhibit a J-shaped relationship with cardiovascular mortality. The association of exogenous testosterone with adverse cardiovascular outcomes is highly dependent on dose and route of administration. Non-oral testosterone administration is associated with neutral risks, but close monitoring of total testosterone levels is obligatory. Estrogen, progesterone, and androgens levels shift during menopause transition, and the ratios between levels have a greater impact on cardiometabolic and cardiovascular outcomes than absolute levels. While exogenous testosterone modestly improves hypoactive sexual desire, it is unknown if restoring testosterone levels to premenopausal physiologic conditions can also mitigate other age-related physical changes. Future studies addressing the timing, dose, route of administration, treatment duration, and combination therapy with estrogen in postmenopausal women of all racial and ethnicities are needed.
PMID:
42573857
Bibliographic data and abstract were imported from PubMed on 10 Aug 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 9
- Comments 0